Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ardizzoni

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
Anticancer Research|March 1, 1991
Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term resultsA Ardizzoni, V Fusco, C Pennucci, et al.
Mini Reviews in Medicinal Chemistry|August 25, 2011
Epidermal growth factor receptor irreversible inhibitors: chemical exploration of the cysteine-trap portionC Carmi, A Lodola, S Rivara, et al.
Cancer Treatment Reports|December 1, 1987
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancerA Ardizzoni, V Fusco, M Gulisano, et al.
La Medicina Del Lavoro|February 7, 2006
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest GroupC Porta, A Ardizzoni, G Gaudino, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2001
Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell linesM Loprevite, R E Favoni, A de Cupis, et al.
Pathologica|October 20, 2011
Reliability of K-ras mutational analysis on cytological samples from metastatic colorectal cancerC Bozzetti, F V Negri, N Naldi, et al.
Cancer|September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patientsL Canobbio, T Fassio, A Ardizzoni, et al.
British Journal of Cancer|November 27, 2001
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)E Baldini, A Ardizzoni, T Prochilo, et al.
Anticancer Research|January 30, 2003
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancerF Grossi, M C Pennucci, J Serrano, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|December 1, 1986
Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancerA Ardizzoni, L Canobbio, P Pronzato, et al.
Anticancer Research|March 1, 1991
Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term resultsA Ardizzoni, V Fusco, C Pennucci, et al.
Mini Reviews in Medicinal Chemistry|August 25, 2011
Epidermal growth factor receptor irreversible inhibitors: chemical exploration of the cysteine-trap portionC Carmi, A Lodola, S Rivara, et al.
Cancer Treatment Reports|December 1, 1987
Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancerA Ardizzoni, V Fusco, M Gulisano, et al.
La Medicina Del Lavoro|February 7, 2006
Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest GroupC Porta, A Ardizzoni, G Gaudino, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2001
Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell linesM Loprevite, R E Favoni, A de Cupis, et al.
Pathologica|October 20, 2011
Reliability of K-ras mutational analysis on cytological samples from metastatic colorectal cancerC Bozzetti, F V Negri, N Naldi, et al.
Cancer|September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patientsL Canobbio, T Fassio, A Ardizzoni, et al.
British Journal of Cancer|November 27, 2001
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)E Baldini, A Ardizzoni, T Prochilo, et al.
Anticancer Research|January 30, 2003
Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancerF Grossi, M C Pennucci, J Serrano, et al.
Pageof 16